Levee Medical Receives FDA Approval for its Landmark ARID II IDE Pivotal Study

Additionally, Company Reaches Significant Enrollment Milestones in Feasibility and Observational Studies Durham, NC – June 10, 2024 – Levee Medical®, a medical device company designing solutions to improve surgical outcomes following prostate cancer, announced today it has received significant funding commitments to support ongoing regulatory and clinical activities. The funds raised will be instrumental in advancing the development of the Voro® Urologic Scaffold and supporting broader clinical studies to further establish its safety and efficacy. The post Levee Medical Receives FDA Approval f